FDA Approved: FOSAPREPITANT — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved the original application for fosaprepitant, a generic antiemetic, to prevent chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

ORIG AP for FOSAPREPITANT (FOSAPREPITANT)